NKCFO LLC’s Select Medical SEM Stock Holding History

NKCFO LLC’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,352	Closed	-$153K	–	156
2021 Q1	$153K	Buy	+8,352	New	+$137K	0.06%	92

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

NKCFO LLC's SEM Position: Q2 2021 in Review

NKCFO LLC sold out of Select Medical (SEM) in Q2 2021, closing a stake of 8,352 shares — an estimated $153K sold.

NKCFO LLC first reported a position in SEM in Q1 2021 and held it in 1 quarter. The position peaked at $153K in Q1 2021. 264 funds tracked by Wall St. Rank hold SEM as of Q2 2021.

NKCFO LLC reported no remaining Select Medical position as of Q2 2021 after selling out during the quarter.
NKCFO LLC sold 8,352 Select Medical shares in Q2 2021, an estimated $153K.
NKCFO LLC first reported a position in Select Medical in Q1 2021 and held it in 1 quarter.
NKCFO LLC's Select Medical position peaked at $153K in Q1 2021.
264 funds tracked by Wall St. Rank held Select Medical as of Q2 2021.

Based on NKCFO LLC's 13F filing for Q2 2021, filed 22 Jul 2021.